Evidence map›Paper›PMID 38679639›Full record

SynthesisSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2024

Survivorship care for people affected by advanced or metastatic cancer: MASCC-ASCO standards and practice recommendations.

Nicolas H Hart, Larissa Nekhlyudov, Thomas J Smith, Jasmine Yee, Margaret I Fitch, Gregory B Crawford, Bogda Koczwara, Fredrick D Ashbury, Maryam B Lustberg, Michelle Mollica and 6 more

Abstract readSystematic Review
In one paragraph

Synthesis in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. PRiSM project: e-Delphi study on the role of specialist palliative care services in the care of people with stable locally advanced or metastatic cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Professional Roles in Danish Clinics for General Late Effects After Cancer-A Qualitative Study.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  6. Article
  7. e-Delphi study on European expert views about "cancer survivor" and related terminologies.Journal of cancer survivorship : research and practice · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Canadian oncology nursing journal = Revue canadienne de nursing oncologique · 2026
    Article
  13. What are the Barriers and Enablers of Survivorship Care Plan Use by Breast and Colorectal Cancer Survivors?Canadian oncology nursing journal = Revue canadienne de nursing oncologique · 2026
    Article
  14. Review
  15. Article
  16. Wellbeing status and priority concerns of patients with advanced renal cell carcinoma: results of the EONS PROMs project international online survey.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Nicolas H HartHuman Performance Research Centre, INSIGHT Research Institute, Faculty of Health, University of Technology Sydney (UTS), Sydney, NSW, Australia. nicolas.hart@uts.edu.au.
Larissa NekhlyudovInternal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Thomas J SmithDivision of General Internal Medicine and Sidney Kimmel Comprehensive Cancer Center, John Hopkins Medical Institutions, Baltimore, MD, USA.
Jasmine YeeCentre for Medical Psychology and Evidence-Based Decision-Making, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Margaret I FitchSchool of Graduate Studies, Faculty of Nursing, University of Toronto, Toronto, ON, Canada.
Gregory B CrawfordFaculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia.
Bogda KoczwaraFlinders Health and Medical Research Institute, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Fredrick D AshburyVieCure, Clinical and Scientific Division, Greenwood Village, CO, USA.
Maryam B LustbergDepartment of Medicine, School of Medicine, Yale University, New Haven, CT, USA.
Michelle MollicaOffice of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
Andrea L SmithThe Daffodil Centre and University of Sydney: a joint venture with Cancer Council NSW, Sydney, NSW, Australia.
Michael JeffordAustralian Cancer Survivorship Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Fumiko ChinoDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Robin ZonMichiana Hematology-Oncology, Mishawaka, IN, USA.
Meera R AgarIMPACCT Research Centre, Faculty of Health, University of Technology Sydney (UTS), Sydney, NSW, Australia.
Raymond J ChanCaring Futures Institute, College of Nursing and Health Science, Flinders University, Adelaide, SA, Australia.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

purposePeople with advanced or metastatic cancer and their caregivers may have different care goals and face unique challenges compared to those with early-stage disease or those nearing the end-of-life. These MASCC-ASCO standards and practice recommendations seek to establish consistent provision of quality survivorship care for people affected by advanced or metastatic cancer.

methodsAn expert panel comprising MASCC and ASCO members was formed. Standards and recommendations relevant to the provision of quality survivorship care for people affected by advanced or metastatic cancer were developed through conducting: (1) a systematic review of unmet supportive care needs; (2) a scoping review of cancer survivorship, supportive care, and palliative care frameworks and guidelines; and (3) an international modified Delphi consensus process.

resultsA systematic review involving 81 studies and a scoping review of 17 guidelines and frameworks informed the initial standards and recommendations. Subsequently, 77 experts (including 8 people with lived experience) across 33 countries (33% were low-to-middle resource countries) participated in the Delphi study and achieved ≥ 94.8% agreement for seven standards (1. Person-Centred Care; 2. Coordinated and Integrated Care; 3. Evidence-Based and Comprehensive Care; 4. Evaluated and Communicated Care; 5. Accessible and Equitable Care; 6. Sustainable and Resourced Care; 7. Research and Data-Driven Care) and ≥ 84.2% agreement across 45 practice recommendations.

conclusionStandards of survivorship care for people affected by advanced or metastatic cancer are provided. These MASCC-ASCO standards will support optimization of health outcomes and care experiences by providing guidance to stakeholders in cancer care (healthcare professionals, leaders, and administrators; governments and health ministries; policymakers; advocacy agencies; cancer survivors and caregivers. Practice recommendations may be used to facilitate future research, practice, policy, and advocacy efforts.

Indexed as

Cancer SurvivorsNeoplasmsPalliative CareSurvivorshipDelphi TechniqueHumansNeoplasm MetastasisPatient-Centered CarePractice Guidelines as TopicQuality of Health CareCancer SurvivorsCaregiversElements of CareSupportive CareSurvivorship

Identifiers

PMID38679639
PMCPMC11056340

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.